Sonnet Biotherapeutics Holdings Inc. (SONN) |
|
2.72 0 (0%)
|
08-14 16:00 |
|
Open: |
2.7 |
Pre. Close: |
2.72 |
|
High:
|
2.72 |
Low:
|
2.56 |
|
Volume:
|
711,759 |
Market Cap:
|
31M |
|
|
|
|
SONNET BioTherapeutics, Inc. is a biotechnology company that engages in development of bi and tri functional therapies that can simulate or block immune-modulating targets to control cancer. The company uses albumin binding single chain antibody fragment (scFv) for delivery of recombinant human-cytokines (rH-cytokines) and other validated targets. SONNET BioTherapeutics, Inc. was incorporated in 2015 and is based in Princeton, New Jersey. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
2.728 - 2.743 |
2.743 - 2.755 |
|
Low:
|
2.515 - 2.536 |
2.536 - 2.552 |
|
Close:
|
2.688 - 2.72 |
2.72 - 2.747 |
|
Technical analysis |
as of: 2020-08-14 4:34:29 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 6.82 One year: 9.22 |
| Support: |
Support1: 2.52 Support2: 2.10 |
| Resistance: |
Resistance1: 5.84 Resistance2: 7.89 |
| Pivot: |
3.08  |
| Moving Average: |
MA(5): 2.78 MA(20): 3.09
MA(100): 4.66 MA(250): 11.90 |
| MACD: |
MACD(12,26): -0.19 Signal(9): -0.15 |
| Stochastic oscillator: |
%K(14,3): 3.23 %D(3): 4.16 |
| RSI: |
RSI(14): 40.04 |
| 52-week: |
High: 54.60 Low: 2.52 Change(%): -82.8 |
| Average Vol(K): |
3-Month: 294319 10-Days: 193760 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.SONN has closed above bottom band by 28.8%. Bollinger Bands are 60% narrower than normal. The narrow width of the bands suggests low volatility as compared to SONN's normal range. The bands have been in this narrow range for 80 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Headline News |
Fri, 14 Aug 2020
Sonnet BioTherapeutics Provides Fiscal Year Third Quarter Business and Earnings Update - BioSpace
Thu, 13 Aug 2020
Sonnet BioTherapeutics Holdings Inc. (SONN) poses a Brand-New Opportunity for Investors with beta value of 1.05 - News Daemon
Wed, 12 Aug 2020
Is Sonnet BioTherapeutics Holdings, Inc. (SONN) a Keeper? Bullish Price Target $7.00 - The News Heater
Tue, 11 Aug 2020
Here is a bargain stock you should look at : Sonnet BioTherapeutics Holdings, Inc. (SONN) - Marketing Sentinel
Tue, 04 Aug 2020
Sonnet BioTherapeutics Announces At-The-Market Warrant Repricing and Exchange Resulting in Expected Gross Proceeds to the Company of up to $10.5 Million - Yahoo Finance
Mon, 03 Aug 2020
Here is why Sonnet BioTherapeutics Holdings Inc. (SONN) stock volatility recorded over the last month was 14.17% - The InvestChronicle
|
Financial Analysis |
| Growth |
n/a |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
n/a |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
n/a |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
n/a |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
